Neurobiologic Advances from the Brain Disease Model of Addiction

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2016 Jan 28

PMID 26816013

Citations 512

Authors

Nora D Volkow

George F Koob

A Thomas McLellan

Affiliations

Soon will be listed here.

Citing Articles

Whole Person Recovery from Substance Use Disorder: A Call for Research Examining a Dynamic Behavioral Ecological Model of Contexts Supportive of Recovery.

Witkiewitz K, Tucker J Addict Res Theory. 2025; 33(1):1-12.

PMID: 40059906 PMC: 11883499. DOI: 10.1080/16066359.2024.2329580.

Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics.

Tiwari P, Berghella A, Sayali C, Doss M, Barrett F, Yaden D Psychedelic Med (New Rochelle). 2025; 1(2):74-86.

PMID: 40046726 PMC: 11658661. DOI: 10.1089/psymed.2023.0010.

The effectiveness of brain wave synchronization in the theta band on depression and anxiety in opioid-dependent patients.

Yari Oskouei S, Mansouriyeh N Addict Health. 2025; 16(4):248-252.

PMID: 39944389 PMC: 11811546. DOI: 10.34172/ahj.1529.

Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges.

Li X, Chen Y, Li X, Yang X, Zhou L, Cheng Y Curr Oncol Rep. 2025; .

PMID: 39913071 DOI: 10.1007/s11912-025-01635-9.

Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial.

OMalley S, Miranda Jr R, Book S, Chun T, Liss T, Malcolm R Alcohol Alcohol. 2025; 60(2).

PMID: 39829301 PMC: 11744046. DOI: 10.1093/alcalc/agaf001.

References

Giedd J, Blumenthal J, Jeffries N, Castellanos F, Liu H, Zijdenbos A . Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999; 2(10):861-3. DOI: 10.1038/13158. View

Busch S, Epstein A, Harhay M, Fiellin D, Un H, Leader Jr D . The effects of federal parity on substance use disorder treatment. Am J Manag Care. 2014; 20(1):76-82. PMC: 3987861. View

Saddoris M, Cacciapaglia F, Wightman R, Carelli R . Differential Dopamine Release Dynamics in the Nucleus Accumbens Core and Shell Reveal Complementary Signals for Error Prediction and Incentive Motivation. J Neurosci. 2015; 35(33):11572-82. PMC: 4540796. DOI: 10.1523/JNEUROSCI.2344-15.2015. View

Wise R . Brain reward circuitry: insights from unsensed incentives. Neuron. 2002; 36(2):229-40. DOI: 10.1016/s0896-6273(02)00965-0. View

Volkow N, Wang G, Telang F, Fowler J, Logan J, Childress A . Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci. 2006; 26(24):6583-8. PMC: 6674019. DOI: 10.1523/JNEUROSCI.1544-06.2006. View

Volkow N, Koob G . Brain disease model of addiction: why is it so controversial?. Lancet Psychiatry. 2015; 2(8):677-679. PMC: 4556943. DOI: 10.1016/S2215-0366(15)00236-9. View

Konova A, Moeller S, Tomasi D, Parvaz M, Alia-Klein N, Volkow N . Structural and behavioral correlates of abnormal encoding of money value in the sensorimotor striatum in cocaine addiction. Eur J Neurosci. 2012; 36(7):2979-88. PMC: 3463641. DOI: 10.1111/j.1460-9568.2012.08211.x. View

Hagele C, Schlagenhauf F, Rapp M, Sterzer P, Beck A, Bermpohl F . Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders. Psychopharmacology (Berl). 2014; 232(2):331-41. PMC: 4297301. DOI: 10.1007/s00213-014-3662-7. View

Stanis J, Andersen S . Reducing substance use during adolescence: a translational framework for prevention. Psychopharmacology (Berl). 2014; 231(8):1437-53. PMC: 3969413. DOI: 10.1007/s00213-013-3393-1. View

10.

Weiss F . Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol. 2005; 5(1):9-19. DOI: 10.1016/j.coph.2004.11.001. View

11.

Jennings J, Sparta D, Stamatakis A, Ung R, Pleil K, Kash T . Distinct extended amygdala circuits for divergent motivational states. Nature. 2013; 496(7444):224-8. PMC: 3778934. DOI: 10.1038/nature12041. View

12.

Sandler I, Wolchik S, Cruden G, Mahrer N, Ahn S, Brincks A . Overview of meta-analyses of the prevention of mental health, substance use, and conduct problems. Annu Rev Clin Psychol. 2014; 10:243-73. PMC: 3984908. DOI: 10.1146/annurev-clinpsy-050212-185524. View

13.

Warner L, Kessler R, Hughes M, Anthony J, Nelson C . Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1995; 52(3):219-29. DOI: 10.1001/archpsyc.1995.03950150051010. View

14.

Potenza M . Perspective: Behavioural addictions matter. Nature. 2015; 522(7557):S62. DOI: 10.1038/522S62a. View

15.

Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y . Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001; 286(14):1715-23. PMC: 3056510. DOI: 10.1001/jama.286.14.1715. View

16.

Volkow N, Tomasi D, Wang G, Logan J, Alexoff D, Jayne M . Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers. Mol Psychiatry. 2014; 19(9):1037-43. PMC: 4827430. DOI: 10.1038/mp.2014.58. View

17.

Zhang Y, Schlussman S, Rabkin J, Butelman E, Ho A, Kreek M . Chronic escalating cocaine exposure, abstinence/withdrawal, and chronic re-exposure: effects on striatal dopamine and opioid systems in C57BL/6J mice. Neuropharmacology. 2012; 67:259-66. PMC: 3616618. DOI: 10.1016/j.neuropharm.2012.10.015. View

18.

Koob G, Moal M . Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci. 2005; 8(11):1442-4. DOI: 10.1038/nn1105-1442. View

19.

Goldstein R, Volkow N . Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011; 12(11):652-69. PMC: 3462342. DOI: 10.1038/nrn3119. View

20.

Schultz W . Getting formal with dopamine and reward. Neuron. 2002; 36(2):241-63. DOI: 10.1016/s0896-6273(02)00967-4. View